Influence of ω-Aminoacids on the Activation of the First Component of Complement at Low Ionic Strength

Summary

Cl, the first component of human complement, was activated to Cls by diluting human plasma in a solution of low ionic strength. The addition of lysine and its related aminoacids to plasma resulted in inhibition of Cl activation, α, ω-diaminoacids such as lysine and ornithine were most effective and ω-aminoacids such as 6 aminohexanoic acid were far less effective. Tranexamic acid which is most potent in inhibition of fibrinolysis among those aminoacids was least effective in the inhibition of Cl activation, ω-aminoacids or their analogues hardly inhibited Cls which had already been activated.

Keywords

Cl - Lysine - 6 AHA - Tranexamic acid

• References

• 1 Haines AL, Lepow IH. Studies on human C’l-esterase. I. Purification and enzymatic properties. J Immunol 1964; 92: 456-467
• 2 Nelson RA JR, Jensen J, Gigli I, Tamura N. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry 1966; 03: 111-135
• 3 Sakai K, Stroud RM. Purification, molecular properties, and activation of Cl proesterase, Cls. J Immunol 1973; 110: 1010-1020
• 4 Soter NA, Austen KF, Gigli I. Inhibition by e-amino-caproic acid of the activation of the first component of complement system. J Immunol 1975; 114: 928-932
• 5 Sheffer AL, Austen KF, Rosen FS. Treatment of hereditary angioneurotic edema with trans-AMCHA. J Allergy Clin Immunol 1972; 49: 133
• 6 Sheffer AL, Fearon DT, Austen KF, Rosen FS. Tranexamic acid. Preoperative prophylactic therapy for patients with hereditary angioneurotic edema. J Allergy Clin Immunol 1977; 60: 38-40
• 7 Donaldson VH, Ratnoff OD, Dias da Silva W, Rosen FS. Permeability-increasing activity in hereditary angioneurotic edema plasma. II Mechanism of formation and partial characterization. J Clin Invest 1969; 48: 642-653
• 8 Takada A, Takada Y. Effects of tranexamic acid, t-AMCHA, and its cis-isomer on the complement system in vitro and in vivo: Possible relationship between coagulation and complement systems. Thrombos Res 1978; 13: 193-205
• 9 Takada Y, Arimoto Y, Mineda H, Takada A. Inhibition of the classical and alternative pathways by amino acids and their derivatives. Immunology 1978; 34: 509-515
• 10 Takada A, Ohashi H, Matsuda H, Takada Y. Effects of tranexamic acid, cis-AMCHA, and 6-aminohexanoic acid on the activation rate of plasminogen by urokinase in the presence of clot. Thrombos Res 1979; 14: 915-923
• 11 Takada A, Urano T, Takada Y. Influence of coagulation on the activation of plasminogen by streptokinase and urokinase. Thromb Haemostas 1979; 42: 901-908
• 12 Trumpi-Kalshoven MM. The relevance of Cl inhibitor in the inhibition of the fibrinolytic activity of plasmin. In: Progress in chemical fibrinolysis and thrombolysis. Davidson JF, Rowan MM, Samama MM, Desnoyers PC. (Eds.) Raven; New York: 1978. vol. 03. 257-267
• 13 Takahashi K, Nagasawa A, Koyama J. The NH₂-terminal sequences of a subunit of the first component of human complement, Cls, and its activated form Cls. FEBS Lett 1975; 50: 330-333
• 14 Roberts PS. Measurement of the rate of plasmin on synthetic substrates. J Biol Chem 1958; 238: 285-291
• 15 Takada A, Takada Y. Interaction of Cls and Cl inactivator in the presence of heparin, dextran sulfate and protamine sulfate. Thromb Res 1980; 18: 847-859
• 16 Harpel PC, Cooper NR. Studies on human plasma Cl inactivator enzyme interactions. I. Mechanism of interaction with Cls, plasmin, and trypsin. J Clin Invest 1975; 55: 593-604
• 17 Ratnoff OD, Naff GB. The conversion of C'ls to C’l esterase by plasmin and trypsin. J Exp Med 1967; 125: 337-358
• 18 Ward PA. A plasmin-split fragment of C’3 as a new chemotactic factor. J Exp Med 1967; 126: 189-206
• 19 Polley MJ, Nachman RL. Human complement in thrombin-mediated platelet function. Uptake of the C5b-9 complex. J Exp Med 1979; 150: 633-645
• 20 Muhlfelder JW, Niemetz J, Kreuzer D, Beebe D, Ward PA, Rosenfeld SI. C5 chemotactic fragment induces leucocyte production of tissue factor activity. A link between complement and coagulation. J Clin Invest 1979; 63: 147-150
• 21 Ratnoff OD, Lepow IH. Some properties of an esterase derived from preparations of the first component of complement. J Exp Med 1957; 106: 327-343
• 22 Alkjaersig N, Fletscher AP, Sherry S. ε-aminocaproic acid: an inhibitor of plasminogen activation. J Biol Chem 1959; 234: 832-837
• 23 Okamoto S, Oshiba S, Mihara H, Okamoto U. Synthetic inhibitors of fibrinolysis: In vitro and in vivo mode of action. Ann NY; Acad Sci: 1968. 146. 414-429
• 24 Iwamoto M. Plasminogen-plasmin system. IX. Specific binding of tranexamic acid to plasmin. Thrombos Diathes Haemorrh 1975; 33: 573-585
• 25 Thorsen S. Influence of fibrin on the effect of 6-aminohexanoic add on fibrinolysis caused by tissue plasminogen activator or urokinase. In: Progress in chemical fibrinolysis and thrombolysis. Davidson JF, Rowan RM, Samama MM, Desnoyers PC. (Eds.) Raven; New York: 1978. vol. 03. 269-281